The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
The sister of one of the British journalists being held on terror charges in Turkey has told how she hopes their "nightmare" will end soon.
Britain's Got Talent star Ryan Howell has died of bone cancer, aged just 18.
It was back to school for children across the country today - and it was no different for the son of England captain Wayne Rooney.